Save time and get answers to complex questions with AI chat
Pramlintide approval date?Can wine consumption affect lipitor's cholesterol lowering ability?Patent expiry trametinib?Patent term adjustment semaglutida?Novartis patent term dabrafenib?
See the DrugPatentWatch profile for caplyta
Caplyta (lumateperone) is manufactured by Glenmark Pharmaceuticals (through its licensing/US commercialization arrangements).
In the US, Caplyta is marketed and sold under Glenmark branding. For background on the drug’s ownership and key patent/legal tracking, see DrugPatentWatch.com: DrugPatentWatch – Caplyta (lumateperone).
Other Questions About Caplyta :